Seminar Series Schedule 2007
An annual Seminar Series is co-sponsored by the Institute for Hepatitis
and Virus Research (IHVR), the Hepatitis B Foundation, and the Drexel
Institute to promote scientific exchange at the national and international
January 17 - Adam Zlotnick, PhD (Univ. of Oklahoma Health Sciences Center)
“HBV assembly as an antiviral target”
February 13 – Richard M. Carlton, PhD
“A mechanism for getting drugs for hepatitis or liver cancer tested and approved in China”
February 16 – David Perlman, PhD (Boston University School of Medicine)
“Biological insight through proteomics: lessons in hepadnaviral capsid dynamics, nitrite-induced cardioprotection, systemic amyloidoses and lymphomagenesis”
March 13 - 4:00 PM – Patrick J Kelly, PhD*
“How biotech companies can prepare for the IP component of venture capital due diligence”
April 10 - 4:00 PM - Stanley Lemon, MD (University of Texas Medical Branch)
“Confounding the host: Evasion of innate immune responses by hepatitis viruses”
April 17 - 4:00 PM - Ed Richman (CEO, Richman Chemicals, Inc)*
“Effective Outsourcing for Start Up Companies”
April 27 - 4:00 PM – Frank Chisari, MD (The Scripps research Institute)
“Determinants of viral persistence in hepatitis virus infection ”
April 30 - 11:00 AMRichard Rest, PhD (Drexel University College of Medicine)
“The road to understanding anthrax pathogenesis: Holes and Tolls”
May 17 - 4:00 PM – Carole Egan DeNatale (Woodcock Washburn, LLP)*
“Strategies for name selection and protection ”
May 21 - 11:00 AM – Uri Galili, PhD (University of Massachusetts Medical School)
"Increasing immunogenicity of viral and cancer vaccines by anti-Gal mediated targeting to APC”
July 12 - 11:00 AM – Andrew Talal, PhD (Weill Cornell Medical College)
“"Chemokines in chronically HCV-infected patients: inflammatory mediators and markers of treatment outcome" ”
July 20 - 11:00 AM – Hui Zhang, PhD (Johns Hopkins University)
“Identification of disease-associated glycopeptides as candidate biomarkers ”
August 30 - 11:00 AM - Rado Goldman, PhD (Georgetown University Medical Center)
"Detection of Hepatocellular Carcinoma: Peptides, Glycans, and Autoantibodies"
September 7 - 11:00 AM - Betsy M. Sutherland, PhD (Brookhaven National Laboratory)
"Repair of Clustered DNA Damages: oligonucleotides, human cells and tissue"
September 12 - 11:00 AM - Weidong Xiao, PhD (University of Pennsylvania School of Medicine)
"AAV vector as a gene transfer tool"
September 24 - 11:00 AM - Young Hann, PhD (University of Virginia)
"Role of HCV-mediated DC dysfunction in regulation of CD4+ T cell responses"
October 5 - 11:00 AM - Stephen Jennings, PhD (Drexel University College of Medicine)
"Cellular Immunity to Herpes Simplex Virus Infections: Implications for Latency and Reactivation"
October 11 -11:00 AM - Jorge Marrero, PhD (University of Michigan)
"Diagnosis and prognosis of hepatocellular carcinoma"
October 25 -11:00 AM - E. John Wherry, PhD (The Wistar Institute)
"Dysfunction and Negative Regulation of Antiviral CD8 T cell Responses During Chronic Infection"
November 9 -7:45 AM - 1:00 PM - Annual RBC Biotech Conference
"Biotech Success Stories: What Big and Small Companies are Looking For"
November 28 - 11:00 AM - David Thomas, MD (Johns Hopkins University School of Medicine)
"Pathogenesis of Chronic Viral Liver Disease In HIV Infected Persons"
December 7th - 11:00 AM - Michael Robek, PhD (Yale University School of Medicine)
"Manipulating the Host Immune Response to Inhibit HBV Replication"
For More Information:
Institute for Hepatitis and Virus Research
3805 Old Easton Road, Doylestown, PA 18902
Please note that all Seminars are held at the IHVR and Drexel Institute
located at the PA Biotechnology
Center of Bucks County in Doylestown, PA. Click
here for Travel Directions.